Back

Imaging-guided risk stratification in transthyretin amyloidosis

28 August 2026 (11:12 - 11:24)
Organised by: Logo
Congress Presentation Part of: Imaging innovations for diagnosis, risk, and therapy in transthyretin amyloidosis Imaging of Myocardial Disease ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Karola Jering

Brigham and Women's Hospital, Boston (United States of America)

4 More presentations in this session

Presentation thumbnail
Novel tracers to improve transthyretin amyloidosis diagnostics
Doctor S. Dorbala (Boston, US)
Slides Video
Presentation thumbnail
Therapy selection based on imaging
Professor M. Pieroni (Florence, IT)
Slides Video
Presentation thumbnail
Monitoring transthyretin amyloidosis diseases using imaging
Doctor M. Hundertmark (Bern, CH)
Slides Video
Presentation thumbnail
Imaging innovations for diagnosis, risk, and therapy in transthyretin amyloidosis - discussion
Video

Access the full session

Session thumbnail
Imaging innovations for diagnosis, risk, and therapy in transthyretin amyloidosis
Video

The Event

Event poster

ESC Congress 2026

28 August 2026 11:12 CET
You may be interested in
thumbnail
Congress Presentation
Monitoring amyloidosis treatment
30 August 2025
thumbnail
Congress Presentation
Native T1 for diagnosis and risk prediction in amyloid transthyretin cardiomyopathy
9 May 2026
thumbnail
Congress Presentation
Seeing the full picture: the impact of imaging on early diagnosis in ATTR-CM
12 December 2025
thumbnail
Congress Session
Looking beyond heart failure: could it be transthyretin amyloid cardiomyopathy (ATTR-CM)?
22 May 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources